Clinical Trial Update: Weight-Based Enoxaparin Dosing and Real-Time Dose Adjustment in Orthopaedic Trauma [Phase 2]

View source ↗

Summary

Phase 2 clinical trial evaluating weight-based enoxaparin dosing with real-time dose adjustment for orthopaedic trauma; study completed with results posted.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Deep Vein Thrombosis
• Pulmonary Embolism
• Venous Thrombosis

Drugs mentioned

• Enoxaparin (enoxaparin sodium)

Snippet

Sponsor: University of Utah | Conditions: Venous Thromboembolism, Deep Vein Thrombosis | Phase 2 | Status: COMPLETED | Results posted: 2024-01-31